Atlas Trials

Molecular Templates, Inc.

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Molecular Templates, Inc.

RecordFirmDate
Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types (NCT06034860)Molecular Templates, Inc.2023-11-01
Study of MT-6402 in Subjects With Advanced Solid Cancer That Expresses PD-L1 (NCT04795713)Molecular Templates, Inc.2021-05-27
A Study of MT-0169 in Participants With Relapsed or Refractory Multiple Myeloma (NCT04017130)Molecular Templates, Inc.2020-02-05
Study of MT-5111 in HER2-positive Solid Tumors (NCT04029922)Molecular Templates, Inc.2019-11-12
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Lenalidomide for the Treatment of Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (MT-3724_NHL_003) (NCT03645395)Molecular Templates, Inc.2019-04-08
PK,PD,Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Gemcitabine and Oxaliplatin for the Treatment of Patients With Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's Lymphoma (NCT03488251)Molecular Templates, Inc.2018-08-20

Track Molecular Templates, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.